Home LiteratureArticle Details
PMID: 22105166 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Comment

Another VCP interactor: NF is enough.

The Journal of clinical investigation ·Vol. 121 ·No. 12 ·2011-12-00 ·Pages 4627-30

Weihl CC

Abstract

Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) is a multisystem degenerative disorder caused by mutations in the valosin-containing protein (VCP) gene. How missense mutations in this abundant, ubiquitously expressed, multifunctional protein lead to the degeneration of disparate tissues is unclear. VCP participates in diverse cellular functions by associating with an expanding collection of substrates and cofactors that dictate its functionality. In this issue of the JCI, Wang and colleagues have further expanded the VCP interactome by identifying neurofibromin-1 (NF1) as a novel VCP interactor in the CNS. IBMPFD-associated mutations disrupt binding of VCP to NF1, resulting in reduced synaptogenesis. Thus, aberrant interactions between VCP and NF1 may explain the dementia phenotype and cognitive delay observed in patients with IBMPFD and neurofibromatosis type 1.

MeSH Terms
Adenosine Triphosphatases/physiology Animals Cell Cycle Proteins/physiology Contracture/congenital,genetics Dendrites/ultrastructure Frontotemporal Dementia/genetics Humans Myositis, Inclusion Body/congenital,genetics Neurofibromatosis 1/genetics Neurofibromin 1/physiology Ophthalmoplegia/genetics Osteitis Deformans/genetics Valosin Containing Protein
Chemicals
Cell Cycle Proteins Neurofibromin 1 Adenosine Triphosphatases VCP protein, human Valosin Containing Protein
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Weihl Conrad C
Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. [email protected]
Supplementary Concepts
Inclusion body myopathy, autosomal dominant (Disease)
References (22)
22 references, click to expand
  1. p97 and close encounters of every kind: a brief review.
    Biochem Soc Trans. 2004 Nov;32(Pt 5):715-20 PMID: 15493996
  2. Molecular and cellular mechanisms of learning disabilities: a focus on NF1.
    Annu Rev Neurosci. 2010;33:221-43 PMID: 20345245
  3. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations.
    Nat Cell Biol. 2011 Aug 07;13(9):1116-23 PMID: 21822278
  4. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease.
    J Biol Chem. 2008 Oct 31;283(44):30289-99 PMID: 18715868
  5. The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.
    Mol Cell Biol. 2010 May;30(9):2264-79 PMID: 20160012
  6. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy.
    Nat Cell Biol. 2007 Apr;9(4):379-90 PMID: 17369820
  7. p97: The cell's molecular purgatory?
    Mol Cell. 2006 Jun 23;22(6):713-717 PMID: 16793541
  8. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    J Cell Biol. 2009 Dec 14;187(6):875-88 PMID: 20008565
  9. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Hum Mol Genet. 2006 Jan 15;15(2):189-99 PMID: 16321991
  10. Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases.
    Brain. 2010 Oct;133(10):2920-41 PMID: 20833645
  11. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.
    J Clin Invest. 2011 Dec;121(12):4820-37 PMID: 22105171
  12. The UNC-45 chaperone mediates sarcomere assembly through myosin degradation in Caenorhabditis elegans.
    J Cell Biol. 2007 Apr 23;177(2):205-10 PMID: 17438072
  13. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis.
    Curr Alzheimer Res. 2011 May;8(3):252-60 PMID: 21222596
  14. Imbalances in p97 co-factor interactions in human proteinopathy.
    EMBO Rep. 2010 Jun;11(6):479-85 PMID: 20414249
  15. Neuronal remodeling and apoptosis require VCP-dependent degradation of the apoptosis inhibitor DIAP1.
    Development. 2011 Mar;138(6):1153-60 PMID: 21343367
  16. Exome sequencing reveals VCP mutations as a cause of familial ALS.
    Neuron. 2010 Dec 9;68(5):857-64 PMID: 21145000
  17. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia.
    Am J Hum Genet. 2007 Jan;80(1):152-61 PMID: 17160902
  18. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.
    Nat Genet. 2004 Apr;36(4):377-81 PMID: 15034582
  19. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin.
    Nature. 2007 Dec 20;450(7173):1258-62 PMID: 18097415
  20. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.
    Mol Cell Biol. 2002 Jan;22(2):626-34 PMID: 11756557
  21. Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins.
    Biochemistry. 2000 Mar 21;39(11):2940-9 PMID: 10715114
  22. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin.
    J Cell Biol. 2010 Dec 27;191(7):1367-80 PMID: 21173115
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
1558-8238
Published
2011-12-00
Epub
2011-00-21
Pages
4627-30
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC3226341
Subset
IM
Grants
NIA NIH HHS · R01 AG031867 · United States
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]